Cocrystal Pharma, Inc. (COCP)
1.07
-0.04
(-3.60%)
USD |
NASDAQ |
Oct 07, 16:00
1.07
0.00 (0.00%)
After-Hours: 16:40
Cocrystal Pharma Net Income (Quarterly) : -3.164M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.164M |
| March 31, 2026 | -2.299M |
| December 31, 2025 | -2.426M |
| September 30, 2025 | -2.049M |
| June 30, 2025 | -2.055M |
| March 31, 2025 | -2.301M |
| December 31, 2024 | -3.266M |
| September 30, 2024 | -4.939M |
| June 30, 2024 | -5.343M |
| March 31, 2024 | -3.956M |
| December 31, 2023 | -4.464M |
| September 30, 2023 | -4.165M |
| June 30, 2023 | -4.166M |
| March 31, 2023 | -5.189M |
| December 31, 2022 | -4.501M |
| September 30, 2022 | -5.70M |
| June 30, 2022 | -24.43M |
| March 31, 2022 | -4.208M |
| December 31, 2021 | -3.685M |
| September 30, 2021 | -3.941M |
| June 30, 2021 | -3.821M |
| March 31, 2021 | -2.738M |
| December 31, 2020 | -1.493M |
| September 30, 2020 | -2.67M |
| June 30, 2020 | -3.495M |
| Date | Value |
|---|---|
| March 31, 2020 | -1.99M |
| December 31, 2019 | -47.84M |
| September 30, 2019 | -1.78M |
| June 30, 2019 | -1.515M |
| March 31, 2019 | 2.971M |
| December 31, 2018 | -44.29M |
| September 30, 2018 | -1.868M |
| June 30, 2018 | -1.343M |
| March 31, 2018 | -1.553M |
| December 31, 2017 | 4.897M |
| September 30, 2017 | -2.26M |
| June 30, 2017 | -1.002M |
| March 31, 2017 | -2.548M |
| December 31, 2016 | -65.75M |
| September 30, 2016 | -1.881M |
| June 30, 2016 | -3.227M |
| March 31, 2016 | -4.012M |
| December 31, 2015 | -30.45M |
| September 30, 2015 | -0.508M |
| June 30, 2015 | -2.623M |
| March 31, 2015 | -16.54M |
| December 31, 2014 | -1.907M |
| September 30, 2014 | -2.549M |
| June 30, 2014 | 4.73M |
| March 31, 2014 | -0.372M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| CNBX Pharmaceuticals, Inc. | -0.1542M |
| Arvinas, Inc. | 169.40M |
| Fulcrum Therapeutics, Inc. | -26.18M |
| Definium Therapeutics, Inc. | -158.99M |
| LeonaBio, Inc. | -19.01M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.105M |
| Total Expenses (Quarterly) | 3.269M |
| EPS Diluted (Quarterly) | -0.2295 |
| Enterprise Value | 14.40M |
| Gross Profit Margin (Quarterly) | 88.57% |
| Profit Margin (Quarterly) | -3.01K% |
| Earnings Yield | -70.91% |
| Normalized Earnings Yield | -70.91 |